In this session, Dr. Jorge Mera, Director of Infectious Diseases for Cherokee Nation Health Services, shares clinical updates on COVID-19. Then, Whitney Essex, Family Nurse Practitioner at Cherokee Nation Health Services,… […]
Type: Past Presentation
Vaping and COVID-19 | CDC, FDA & Clinical Research Updates | August 17, 2020
In this series of presentations, Brigg Reilley, MPH, provides a number of valuable COVID-19 related resources produced by the FDA and CDC as well as an overview of recent updates in COVID-19… […]
Read More… from Vaping and COVID-19 | CDC, FDA & Clinical Research Updates | August 17, 2020
Culture-based Strategies for Substance Use Disorder: Decolonizing Addiction | August 13, 2020
Dr. Melissa Lewis, Assistant Professor in Family and Community Medicine at the University of Missouri, reviews the origins of substance use, Cherokee values of wellbeing, Indigenous understanding of cause of substance… […]
COVID-19 Related Diabetes: Can COVID-19 Cause Diabetes? | August 13, 2020
Dr. Mary Carol Greenlee, a practitioner at Western Slope Endocrinology in Grand Junction, Colorado, examines recent articles and opinions regarding the possibility that COVID-19 can directly result in new onset… […]
Read More… from COVID-19 Related Diabetes: Can COVID-19 Cause Diabetes? | August 13, 2020
Clinical Update | August 12, 2020
In this session, Dr. Jorge Mera, Director of Infectious Diseases for Cherokee Nation Health Services, shares clinical updates on COVID-19. […]
Barriers to Hepatitis C Care Facing People Who Use Drugs | August 11, 2020
Lauren Canary, an infectious diseases epidemiologist, shares information on the barriers to care for hepatitis C facing people who use drugs, and provides some strategies providers can use to help… […]
Read More… from Barriers to Hepatitis C Care Facing People Who Use Drugs | August 11, 2020
Neurological Manifestations of COVID-19 | Question & Answer Panel | August 10, 2020
In this series of presentations, Dr. Thomas Becker provides an overview of the neurological manifestations in COVID-19 patients. Then, ECHO faculty answer questions submitted during the telehealth session – from… […]
Read More… from Neurological Manifestations of COVID-19 | Question & Answer Panel | August 10, 2020
Substance Use Disorders: Brains, Behavior and Diagnosis | August 6, 2020
Dr. Jessica Gregg, SUD ECHO Medical Director and Associate Professor of Medicine at Oregon Health and Science University, reviews the diagnostic criteria for substance use disorders and examines the different… […]
Read More… from Substance Use Disorders: Brains, Behavior and Diagnosis | August 6, 2020
Substance Use Disorders: Brains, Behavior & Diagnosis | August 6, 2020
Dr. Jonathan Robbins, an Assistant Professor of Medicine at Oregon Health & Science University, shares information to help interpret a “negative” benzodiazepine urine drug screen, discusses how to the determine… […]
Read More… from Substance Use Disorders: Brains, Behavior & Diagnosis | August 6, 2020
Considerations for COVID-19 Vaccine & Preparation for Influenza | Clinical Update | August 5, 2020
In this series of presentations, Dr. Jorge Mera, Director of Infectious Diseases for Cherokee Nation Health Services, shares clinical updates on COVID-19. Then, Dr. Thomas Weiser discusses considerations for preparing… […]



















































































